Every 8-K that Concentra Group Holdings Parent, Inc. (CON) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow CON and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CON filings page.
Concentra Group Holdings Parent, Inc. (CON) announced that Tanner Newton has been appointed Executive Vice President and Chief Financial Officer, effective November 1, 2026, as part of a previously announced multiyear leadership succession plan. On that date, current President and CFO Matthew DiCanio will become President and Chief Executive Officer, and Keith Newton will move from CEO to Executive Chairman of the Board of Directors.
Tanner Newton, age 34, is currently Senior Vice President, Strategy & Finance and previously worked in private equity at Tailwater Capital LLC and in investment banking at Piper Sandler & Co. He holds a Master of Science in Finance and bachelor’s degrees in accounting and business honors from Texas A&M University. He is the son of Keith Newton, a current director and the company’s CEO. The company states there are no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K and expects to enter into an employment agreement with him, with compensation terms to be disclosed in a later filing.
Concentra Group Holdings Parent, Inc. (CON) entered into a Stock Repurchase Agreement with chairman Robert A. Ortenzio and related entities to buy back 1,000,000 shares of common stock in a privately negotiated transaction. The company agreed to pay $34.65 per share, for a total of $34,650,000, representing a 1% discount to the August 21, 2026 closing price.
The transaction was approved by the Board’s Audit and Compliance Committee, which is comprised solely of independent directors, and closed on August 24, 2026. It was funded with the company’s cash on hand and executed under Concentra’s previously announced share repurchase program. The repurchased shares represent approximately 0.784% of the company’s issued and outstanding common stock immediately prior to the transaction.
Concentra Group Holdings Parent, Inc. reported strong results for the quarter ended June 30, 2026, with revenue of $606.0 million, up 10.0% year over year, net income of $67.3 million, up 45.7%, and Adjusted EBITDA of $140.9 million, up 22.5% for a 23.3% margin. Earnings per share were $0.51, while net cash from operations reached $135.2 million and Free Cash Flow was $121.0 million. The company ended the quarter with $158.0 million of cash, total debt of $1,573.6 million and a net leverage ratio of 2.99x.
The board declared a $0.0625 per share cash dividend payable on or about August 28, 2026, and the company repurchased about 0.4 million shares for $11.0 million. Leadership succession was announced: Keith Newton will step down as CEO to become executive chairman, and current president and CFO Matt DiCanio will become president, CEO and a Class III director, all effective November 1, 2026. Concentra raised its full-year 2026 guidance to revenue of $2.325–$2.375 billion, Adjusted EBITDA of $485–$495 million, Free Cash Flow of $220–$240 million, and continues to target a net leverage ratio below 3.0x.
Concentra Group Holdings Parent, Inc. outlined post-retirement arrangements for Executive Vice President and Chief Medical Officer Dr. John R. Anderson. Following his previously disclosed retirement effective December 31, 2026, Dr. Anderson will transition to a part-time consulting role with subsidiary Concentra Health Services, Inc.
The consulting agreement is effective from January 1, 2027 through December 31, 2027, with either party able to terminate on 30 days’ notice and Concentra able to terminate immediately for Cause. Dr. Anderson will provide up to 10 hours of consulting services per week at $216.00 per hour, and his outstanding unvested restricted stock awards under the 2024 Equity Incentive Plan will continue to vest during the term while he provides services. If he completes the term without termination for Cause or voluntary resignation, 25% of his then-unvested restricted stock will vest, while all unvested equity will be forfeited upon earlier termination for Cause or voluntary resignation, subject to execution of specified releases.
Concentra Group Holdings Parent, Inc. reported strong first-quarter 2026 results with revenue of $569.6 million, up 13.7% from a year earlier, driven by higher visit volumes and revenue per visit. Net income rose 28.7% to $52.3 million, and earnings per share increased to $0.39 from $0.30. Adjusted EBITDA reached $120.7 million, a 17.6% increase, with margin improving to 21.2%.
The company generated $9.9 million of Free Cash Flow, repurchased about 0.7 million shares for $15.0 million, and ended the quarter with $61.7 million of cash and a net leverage ratio of roughly 3.4x. The board declared a quarterly cash dividend of $0.0625 per share payable in June 2026. Concentra raised its full-year 2026 guidance, now expecting revenue of $2.275–$2.375 billion, Adjusted EBITDA of $460–$480 million, Free Cash Flow of $215–$235 million, capital expenditures of $70–$80 million, and a year-end net leverage ratio below 3.0x.
Concentra Group Holdings Parent, Inc. reported the results of its annual stockholder meeting. Three Class II directors—Vipin Gopal, William K. Newton, and Marc R. Watkins, MD—were elected to serve until the 2029 annual meeting, with each nominee receiving strong support based on votes cast.
Stockholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 114,180,227 votes in favor and 5,143,479 against. In addition, stockholders ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 121,568,869 votes for and 360,888 against.
Concentra Group Holdings Parent, Inc. announced that Executive Vice President and Chief Medical Officer Dr. John Anderson will retire effective December 31, 2026, after 33 years with the company. He plans to continue advising Concentra under a consulting arrangement to support a smooth transition while the company conducts a formal search for his successor.
Dr. Anderson has served as Chief Medical Officer since 2014 and is widely involved in occupational and environmental medicine organizations. Concentra describes itself as the largest U.S. provider of occupational health services by number of locations, with approximately 13,000 colleagues supporting care for about 53,000 patients each business day across 47 states and the District of Columbia as of December 31, 2025.
Concentra Group Holdings Parent, Inc. reported strong growth for Q4 and full-year 2025 and declared a cash dividend. Fourth-quarter revenue rose to $539.1 million, up 15.9% from Q4 2024, with net income increasing 58.7% to $36.2 million. Adjusted EBITDA reached $95.3 million, up 22.9%, helped by higher patient volumes and revenue per visit.
For 2025, revenue grew 13.9% to $2.16 billion and Adjusted EBITDA rose 14.6% to $431.9 million, while net income was roughly flat at $172.8 million. The company generated $197.8 million of Free Cash Flow and ended the year with a 3.4x net leverage ratio.
The board declared a quarterly cash dividend of $0.0625 per share, payable in March 2026 to stockholders of record in mid-March. For 2026, Concentra guides to revenue of $2.25–$2.35 billion, Adjusted EBITDA of $450–$470 million, Free Cash Flow of $200–$225 million, capital expenditures of $70–$80 million, and a net leverage ratio at or below 3.0x.
Concentra Group Holdings Parent, Inc. furnished an 8-K to share a press release with preliminary, unaudited results for certain operating metrics for the fourth quarter and fiscal year ended December 31, 2025. The press release is included as Exhibit 99.1.
The company also furnished an investor presentation (Exhibit 99.2) and an investor book (Exhibit 99.3) published in connection with the same press release. These materials are furnished under Items 2.02 and 7.01 of the Exchange Act and are not deemed filed or incorporated by reference into other securities filings.
Concentra Group Holdings Parent, Inc. furnished an investor presentation containing preliminary, unaudited operational metrics for the quarter ended December 31, 2025. The presentation, filed as Exhibit 99.1, will be used at the J.P. Morgan Healthcare Conference at 9:00 A.M. PT on January 14 and a recording will later be posted on the company’s investor relations website. The information is being provided under Items 2.02 and 7.01 and is designated as furnished rather than filed, meaning it is not subject to certain liability provisions and is not automatically incorporated into other Securities Act or Exchange Act filings.
Concentra Group Holdings Parent, Inc. (CON) disclosed new executive equity awards. On November 4, 2025, the Board’s Human Capital and Compensation Committee granted restricted shares to the company’s named executive officers under the 2024 Equity Incentive Plan. These restricted stock awards vest in equal installments on each of the first four anniversaries of the grant date.
Grants by executive:
- W. Keith Newton: 225,000 shares
- Matthew T. DiCanio: 180,000 shares
- John A. deLorimier: 60,000 shares
- John Anderson: 60,000 shares
- Michael Kosuth: 60,000 shares
- Su Zan Nelson: 60,000 shares
The awards are time-based and align compensation with multi-year service and performance horizons via four-year ratable vesting.
Concentra Group Holdings Parent, Inc. announced two capital return actions alongside furnishing its third‑quarter results materials. The Board declared a cash dividend of $0.0625 per share, payable on or about December 9, 2025 to stockholders of record as of the close of business on December 2, 2025.
The Board also authorized a share repurchase program of up to $100 million of common stock, expiring on December 31, 2027. Repurchases may occur in the open market or through privately negotiated transactions, and the program will be funded with cash on hand. The company furnished a press release and financial presentation for the quarter ended September 30, 2025 as exhibits.
Concentra Group Holdings Parent, Inc. (CON) furnished a press release and financial schedules announcing results for the quarter ended June 30, 2025 (Exhibit 99.1) and published a related presentation (Exhibit 99.2) on August 7, 2025. The filing states these items are furnished under Item 2.02 and Item 7.01 and are not "filed" for purposes of Section 18 of the Exchange Act.
Dividend: On August 6, 2025, the Board declared a cash dividend of $0.0625 per share, payable on or about August 28, 2025, to stockholders of record at the close of business on August 21, 2025. Exhibits listed in the report are 99.1 (press release), 99.2 (presentation) and 104 (Cover Page iXBRL). The report is signed by Timothy Ryan, Executive Vice President and Chief Legal Counsel, dated August 7, 2025.
Concentra Group Holdings Parent (NYSE:CON) filed an 8-K disclosing the Board’s appointment of Brigid Bonner and Vipin Gopal as independent directors, effective July 1, 2025. Bonner’s term runs to the 2027 AGM, while Gopal’s term extends to the 2026 AGM, after which each will stand for shareholder election. Compensation will follow the existing non-employee director program detailed in the 2025 proxy. The Company reported no related-party transactions or special arrangements tied to these appointments. A press release announcing the changes was furnished as Exhibit 99.1; the information was provided under Items 5.02, 7.01 and 9.01 and is deemed furnished, not filed.